Literature DB >> 2420876

Isolation and characterization of an antigen-specific suppressor inducer molecule from serum of hyperimmune mice by using a monoclonal antibody.

T A Ferguson, G M Iverson.   

Abstract

We have used a rat monoclonal antibody (mAb) (called 14-30) to affinity purify the antigen-binding chain of a suppressor inducer factor (TsiF-AB) from the serum of mice hyperimmune to heterologous erythrocytes. The TsiF-AB requires the addition of a second, antigen-nonspecific component for biologic activity as well as Lyt-2+ T cells in the assay culture. This mAb can be used to affinity purify suppressor inducer factor from a well-characterized TsiF but not suppressor effector factor (TseF) from culture supernatants. Binding of mAb 14-30 to TsiF is independent of the antigen specificity of the suppressor factor and of the strain of origin of the TsiF. The TsiF affinity purified from hyperimmune serum has an apparent m.w. of 68,000 by SDS-PAGE analysis. 2D gel analysis shows that the serum-derived TsiF has charge heterogeneity, all in the acid range.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420876

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Initial immunochemical characterization of specific macrophage-arming factor.

Authors:  R A De Weger; R J Vandebriel; H Slager; D Mans; H Van Loveren; B Wilbrink; H F Dullens; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi.

Authors:  L V Rizzo; E Cunha-Neto; A R Teixeira
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells.

Authors:  Thomas S Griffith; Erik L Brincks; Prajwal Gurung; Tamara A Kucaba; Thomas A Ferguson
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.